Bentamapimod

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBentamapimod
Drug Alias NameBentamapimodum本玛莫德贝马莫德JNK inhibitor - Merck SeronoPGL-5 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase 1 inhibitors
Targetsc-Jun N-terminal kinase 1
Therapy Area/IndicationsEndometriosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPreglem Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPreglem Sa
Active IndicationsN/A
Inactive IndicationsEndometriosis

Other Information

ATC CodeN/A
Related LinksN/A